Evidence map›Paper›PMID 32566941›Full record

ArticleJournal of medical entomology2020

Toxicological Evaluation of Novel Butenolide Pesticide Flupyradifurone Against Culex quinquefasciatus (Diptera: Culicidae) Mosquitoes.

Mohamed Ahmed Ibrahim Ahmed, Christoph Franz Adam Vogel

Open access · bronzeAbstract read
In one paragraph

Article in Journal of medical entomology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 4 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 2 countries.

Mohamed Ahmed Ibrahim AhmedPlant Protection Department, Faculty of Agriculture, Assiut University, Assiut, Egypt.
Christoph Franz Adam VogelCenter for Health and the Environment, University of California, Davis, CA.
University of California, Davis · US

Funding

UC Davis Environmental Health Sciences Core CenterP30ES023513 · NIEHS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI Ameer Taha · 2015 to 2026
$26.0M
NIEHS NIH HHS P30 ES023513
6 · The paper itself

Abstract

The impact of increasing resistance of mosquitoes to conventional pesticides has led to investigate various unique tools and pest control strategies. Herein, we assessed the potency of flupyradifurone, a novel pesticide, on fourth instar larvae of Culex quinquefasciatus Say. Further, we evaluated the synergistic action of piperonyl butoxide (PBO) and the octopamine receptor agonists (OR agonists) chlordimeform (CDM) and amitraz (AMZ) on the toxicity of flupyradifurone in comparison with sulfoxaflor and nitenpyram to increase their toxicity on Cx. quinquefasciatus. Results demonstrated that flupyradifurone was the most potent pesticide followed by sulfoxaflor and nitenpyram. Further, the synergetic effect of PBO, CDM, and AMZ was significant for all selected pesticides especially flupyradifurone. However, AMZ had the most significant effect in combination with the selected pesticides followed by CDM and PBO. The toxicity of the pesticides was time-dependent and increased over time from 24, 48, to 72 h of exposure in all experiments. The results indicate that flupyradifurone is a promising component in future mosquito control programs.

Indexed as

ChlorphenamidineCulexInsecticidesMosquito ControlPiperonyl ButoxidePyridinesToluidines4-ButyrolactoneAnimalsInsect ProteinsLarvaNeonicotinoidsReceptors, Biogenic AmineSulfur Compounds4-ButyrolactoneamitrazChlorphenamidineflupyradifuroneInsecticidesInsect ProteinsNeonicotinoidsnitenpyramnorsynephrine receptorPiperonyl ButoxidePyridinesReceptors, Biogenic AminesulfoxaflorSulfur CompoundsToluidinesCulex quinquefasciatusflupyradifuronemosquito controloctopamine receptor agonists (OR agonists)piperonyl butoxide (PBO)

Identifiers

PMID32566941
PMCPMC9989836
OpenAlexW3035850612

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.